| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |